Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IDEBENONE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schols, L; Vorgerd, I; Schillings, M; Skipka, G; Zange, J
      Idebenone in patients with Friedreich ataxia

      NEUROSCIENCE LETTERS
    2. Wieland, E; Shipkova, M; Schutz, E; Braun, F; Niedmann, PD; Armstrong, VW; Ringe, B; Svinarov, DA; Oellerich, M
      Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liverperfusion model

      CLINICAL BIOCHEMISTRY
    3. Napolitano, A; Salvetti, S; Vista, M; Lombardi, V; Siciliano, G; Giraldi, C
      Long-term treatment with idebenone and riboflavin in a patient with MELAS

      NEUROLOGICAL SCIENCES
    4. Mashima, Y; Kigasawa, K; Wakakura, M; Oguchi, Y
      Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?

      JOURNAL OF NEURO-OPHTHALMOLOGY
    5. Zagvazdin, Y; Bodo, M; Sarkadi, A; Szporny, L
      Cerebroprotective drugs shorten the hypoxia-induced onset of electrical silence in unanesthetized rats

      PHARMACOLOGICAL RESEARCH
    6. Kim, HJ; Yoon, KA; Hahn, M; Park, ES; Chi, SC
      Preparation and in vitro evaluation of self-microemulsifying drug deliverysystems containing idebenone

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    7. Thal, LJ
      Trials to slow progression and prevent disease onset

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    8. Hu, P; Jiang, J; Xie, HH
      Determination of idebenone in plasma by HPLC/MS

      ACTA PHARMACOLOGICA SINICA
    9. Weyer, G; Eul, A; Milde, K; Wierich, W; Herrmann, WM
      Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: Experience from a placebo controlled multi-center study

      PHARMACOPSYCHIATRY
    10. Bjorklof, K; Zickermann, V; Finel, M
      Purification of the 45 kDa, membrane bound NADH dehydrogenase of Escherichia coli (NDH-2) and analysis of its interaction with ubiquinone analogues

      FEBS LETTERS
    11. Takuma, K; Yoshida, T; Lee, E; Mori, K; Kishi, T; Baba, A; Matsuda, T
      CV-2619 protects cultured astrocytes against reperfusion injury via nerve growth factor production

      EUROPEAN JOURNAL OF PHARMACOLOGY
    12. Sasaki, T; Matuoka, N; Kubodera, A; Ishii, SI; Goto, G; Senda, M
      Synthesis of [C-11] coenzyme Q-related compounds for in vivo estimation ofmitochondrial electron transduction and redox state in brain

      NUCLEAR MEDICINE AND BIOLOGY
    13. Rego, AC; Santos, MS; Oliveira, CR
      Influence of the antioxidants vitamin E and idebenone on retinal cell injury mediated by chemical ischemia, hypoglycemia, or oxidative stress

      FREE RADICAL BIOLOGY AND MEDICINE
    14. Chariot, P; Brugieres, P; Eliezer-Vanerot, MC; Geny, C; Binaghi, M; Cesaro, P
      Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy

      MOVEMENT DISORDERS
    15. Liu, XJ; Wu, WT
      Effects of ligustrazine, tanshinone II A, ubiquinone, and idebenone on mouse water maze performance

      ACTA PHARMACOLOGICA SINICA
    16. Civenni, G; Bezzi, P; Trotti, D; Volterra, A; Racagni, G
      Inhibitory effect of the neuroprotective agent idebenone on arachidonic acid metabolism in astrocytes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. LEONARD BE
      ADVANCES IN THE DRUG-TREATMENT OF ALZHEIMERS-DISEASE

      Human psychopharmacology
    18. NAKAGAWA K; TAJIMA K
      EFFECTS OF 1-PROPANOL ADDITION ON QUINONE RADICAL FORMATIONS IN MICELLAR SOLUTIONS

      Langmuir
    19. FRESTA M; VENTURA CA; MEZZASALMA E; PUGLISI G
      A CALORIMETRIC STUDY ON THE IDEBENONE-PHOSPHOLIPID MEMBRANE INTERACTION

      International journal of pharmaceutics
    20. HIRAI K; HAYAKO H; KATO K; MIYAMOTO M
      IDEBENONE PROTECTS HIPPOCAMPAL-NEURONS AGAINST AMYLOID BETA-PEPTIDE-INDUCED NEUROTOXICITY IN RAT PRIMARY CULTURES

      Naunyn-Schmiedeberg's archives of pharmacology
    21. CARELLI V; BARBONI P; ZACCHINI A; MANCINI R; MONARI L; CEVOLI S; LIGUORI R; SENSI M; LUGARESI E; MONTAGNA P
      LEBERS HEREDITARY OPTIC NEUROPATHY (LHON) WITH 14484 ND6 MUTATION IN A NORTH-AFRICAN PATIENT/

      Journal of the neurological sciences
    22. SCHAFFLER K; HADLER D; STARK M
      DOSE-EFFECT RELATIONSHIP OF IDEBENONE IN AN EXPERIMENTAL CEREBRAL DEFICIT MODEL - PILOT-STUDY IN HEALTHY-YOUNG VOLUNTEERS WITH PIRACETAM ASREFERENCE DRUG

      Arzneimittel-Forschung
    23. YAMADA K; MASHIMA Y; KIGASAWA K; MIYASHITA K; WAKAKURA M; OGUCHI Y
      HIGH-INCIDENCE OF VISUAL RECOVERY AMONG 4 JAPANESE PATIENTS WITH LEBER HEREDITARY OPTIC NEUROPATHY WITH THE 14484-MUTATION

      Journal of neuro-ophthalmology
    24. IHARA Y; KIBATA M; HAYABARA T; KATAYAMA S; KONISHI H; MIURA K; KOHNO M; KAWAI M; YOKOI I; MORI A
      FREE-RADICALS IN THE CEREBROSPINAL-FLUID ARE ASSOCIATED WITH NEUROLOGICAL DISORDERS INCLUDING MITOCHONDRIAL ENCEPHALOMYOPATHY

      Biochemistry and molecular biology international
    25. OHTA H; NISHIKAWA H; KIMURA H; ANAYAMA H; MIYAMOTO M
      CHRONIC CEREBRAL HYPOPERFUSION BY PERMANENT INTERNAL CAROTID LIGATIONPRODUCES LEARNING IMPAIRMENT WITHOUT BRAIN-DAMAGE IN RATS

      Neuroscience
    26. PLUTA R; BARCIKOWSKA M; DEBICKI G; RYBA M; JANUSZEWSKI S
      CHANGES IN AMYLOID PRECURSOR PROTEIN AND APOLIPOPROTEIN-E IMMUNOREACTIVITY FOLLOWING ISCHEMIC BRAIN INJURY IN RAT WITH LONG-TERM SURVIVAL -INFLUENCE OF IDEBENONE TREATMENT

      Neuroscience letters
    27. WEYER G; BABEJDOLLE RM; HADLER D; HOFMANN S; HERRMANN WM
      A CONTROLLED-STUDY OF 2 DOSES OF IDEBENONE IN THE TREATMENT OF ALZHEIMERS-DISEASE

      Neuropsychobiology
    28. BET L; ORSINA N; CELESTE S; RAPUZZI S; PIFFERI S; SCARLATO G; MARIANI C
      IDEBENONE INDUCES OXYGEN-CONSUMPTION RATE MODIFICATIONS IN AGED RAT-BRAIN MITOCHONDRIA

      Archives of gerontology and geriatrics
    29. YAMADA K; NITTA A; HASEGAWA T; FUJI K; HIRAMATSU M; KAMEYAMA T; FURUKAWA Y; HAYASHI K; NABESHIMA T
      ORALLY-ACTIVE NGF SYNTHESIS STIMULATORS - POTENTIAL THERAPEUTIC AGENTS IN ALZHEIMERS-DISEASE

      Behavioural brain research
    30. CORTELLI P; MONTAGNA P; PIERANGELI G; LODI R; BARBONI P; LIGUORI R; CARELLI V; IOTTI S; ZANIOL P; LUGARESI E; BARBIROLI B
      CLINICAL AND BRAIN BIOENERGETICS IMPROVEMENT WITH IDEBENONE IN A PATIENT WITH LEBERS HEREDITARY OPTIC NEUROPATHY - A CLINICAL AND P-31-MRS STUDY

      Journal of the neurological sciences
    31. SCHUTZ E; WIELAND E; HENSEL A; NIEDMANN PD; DREISS A; ARMSTRONG VW; SCHUFFWERNER P; OELLERICH M
      SUPPRESSION OF LEUKOCYTE-ENHANCED COLD ISCHEMIA REPERFUSION INJURY OFLIVER ENDOTHELIUM WITH THE BENZOQUINONE ANTIOXIDANT IDEBENONE/

      Clinical biochemistry
    32. INAGAKI T; ISHINO H; SENO H; OHGUNI S; TANAKA J; KATO Y
      PSYCHIATRIC-SYMPTOMS IN A PATIENT WITH DIABETES-MELLITUS ASSOCIATED WITH POINT MUTATION IN MITOCHONDRIAL-DNA

      Biological psychiatry
    33. ONISHI H; KAWANISHI C; IWASAWA T; OSAKA H; HANIHARA T; INOUE K; YAMADA Y; KOSAKA K
      DEPRESSIVE DISORDER DUE TO MITOCHONDRIAL TRANSFER RNA(LEU(UUR)) MUTATION

      Biological psychiatry
    34. SCAVINI C; ROZZA A; LANZA E; FAVALLI L; RACAGNI G; BRUNELLO N
      EFFECT OF IDEBENONE ON IN-VIVO SEROTONIN RELEASE AND SEROTONERGIC RECEPTORS IN YOUNG AND AGED RATS

      European neuropsychopharmacology
    35. PUGLISI G; VENTURA CA; FRESTA M; VANDELLI MA; CAVALLARO G; ZAPPALA M
      PREPARATION AND PHYSICOCHEMICAL STUDY OF INCLUSION COMPLEXES BETWEEN IDEBENONE AND MODIFIED BETA-CYCLODEXTRINS

      Journal of inclusion phenomena and molecular recognition in chemistry
    36. WEYER G; ERZIGKEIT H; HADLER D; KUBICKI S
      EFFICACY AND SAFETY OF IDEBENONE IN THE LONG-TERM TREATMENT OF ALZHEIMERS-DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY

      Human psychopharmacology
    37. RANEN NG; PEYSER CE; COYLE JT; BYLSMA FW; SHERR M; DAY L; FOLSTEIN MF; BRANDT J; ROSS CA; FOLSTEIN SE
      A CONTROLLED TRIAL OF IDEBENONE IN HUNTINGTONS-DISEASE

      Movement disorders
    38. KONDO Y; OGAWA N; ASANUMA M; MATSUURA K; NISHIBAYASHI S; IWATA E
      PREVENTIVE EFFECTS OF BIFEMELANE HYDROCHLORIDE ON DECREASED LEVELS OFMUSCARINIC ACETYLCHOLINE-RECEPTOR AND ITS MESSENGER-RNA IN A RAT MODEL OF CHRONIC CEREBRAL HYPOPERFUSION

      Neuroscience research
    39. SHIGEMITSU T; MAJIMA Y
      USE OF BIFEMELANE HYDROCHLORIDE IN IMPROVING AND MAINTAINING THE VISUAL-FIELD OF PATIENTS WITH GLAUCOMA

      Clinical therapeutics
    40. PISANO P; DURAND A; AUTRET E; DESNUELLE C; PINSARD N; SERRATRICE G; LEGOUT V; JOUBERT M; BLIN O
      PLASMA-CONCENTRATIONS AND PHARMACOKINETICS OF IDEBENONE AND ITS METABOLITES FOLLOWING SINGLE AND REPEATED DOSES IN YOUNG-PATIENTS WITH MITOCHONDRIAL ENCEPHALOMYOPATHY

      European Journal of Clinical Pharmacology
    41. MASHIMA Y; HIIDA Y; OGUCHI Y
      LACK OF DIFFERENCES AMONG MITOCHONDRIAL-DNA IN FAMILY MEMBERS WITH LEBERS HEREDITARY OPTIC NEUROPATHY AND DIFFERING VISUAL OUTCOMES

      Journal of neuro-ophthalmology
    42. AMANO T; TERAO S; IMADA I
      EFFECTS OF ROXYDECYL)-2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE (IDEBENONE) AND RELATED BENZOQUINONES ON PORCINE PANCREAS PHOSPHOLIPASE A(2) ACTIVITY

      Biological & pharmaceutical bulletin
    43. CURTI D; IZZO E; BRAMBILLA L; FACCHETTI G; SANGIOVANNI G; BRAMBILLA G
      EFFECT OF A UBIQUINONE-LIKE MOLECULE ON OXIDATIVE ENERGY-METABOLISM IN RAT CORTICAL SYNAPTOSOMES AT DIFFERENT AGES

      Neurochemical research
    44. NABESHIMA T
      NERVE GROWTH-FACTOR STRATEGY AND PREPARAT ION OF ANIMAL-MODEL FOR ALZHEIMER-TYPE SENILE DEMENTIA

      Yakugaku zasshi
    45. TAKAHASHI K; YAMAMOTO M; SUZUKI M; OZAWA Y; YAMAGUCHI T; ANDOH H; ISHIKAWA K
      EFFECTS OF CEREBRAL METABOLIC ENHANCERS ON BRAIN-FUNCTION IN RODENTS

      Current therapeutic research
    46. GRUNBERGER J; LINZMAYER L; SALETU B; GRUNBERGER M
      A NEW APPROACH TO THE PSYCHOPHARMACOLOGIC AL PUPILLARY OSCILLATIONS HYPOTHESIS AFTER ADMINISTRATION OF A NOOTROPIC COMPOUND

      Arzneimittel-Forschung
    47. WALKER UA; BYRNE E
      THE THERAPY OF RESPIRATORY-CHAIN ENCEPHALOMYOPATHY - A CRITICAL-REVIEW OF THE PAST AND CURRENT PERSPECTIVE

      Acta neurologica Scandinavica
    48. HIROKAWA S; NOSE M; ISHIGE A; AMAGAYA S; OGIHARA Y
      EFFECT OF HACHIMIJIOGAN, AN ORIENTAL HERBAL MEDICINAL MIXTURE, ON EXPERIMENTAL AMNESIA IN MICE

      Biological & pharmaceutical bulletin
    49. NAKAMURA S; KANEKO S; SATOH M
      POTENTIATION OF ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONIC-ACID (AMPA)-SELECTIVE GLUTAMATE-RECEPTOR FUNCTION BY A NOOTROPIC DRUG,IDEBENONE

      Biological & pharmaceutical bulletin
    50. TAKEI M; HIRAMATSU M; MORI A
      INHIBITORY EFFECTS OF CALCIUM-ANTAGONISTS ON MITOCHONDRIAL SWELLING-INDUCED BY LIPID-PEROXIDATION OR ARACHIDONIC-ACID IN THE RAT-BRAIN IN-VITRO

      Neurochemical research
    51. BRUNO V; BATTAGLIA G; COPANI A; SORTINO MA; CANONICO PL; NICOLETTI F
      PROTECTIVE ACTION OF IDEBENONE AGAINST EXCITOTOXIC DEGENERATION IN CULTURED CORTICAL-NEURONS

      Neuroscience letters
    52. NABESHIMA T; NITTA A; FUJI K; KAMEYAMA T; HASEGAWA T
      ORAL-ADMINISTRATION OF NGF SYNTHESIS STIMULATORS RECOVERS REDUCED BRAIN NGF CONTENT IN AGED RATS AND COGNITIVE DYSFUNCTION IN BASAL-FOREBRAIN-LESIONED RATS

      Gerontology
    53. NITTA A; MURAKAMI Y; FURUKAWA Y; KAWATSURA W; HAYASHI K; YAMADA K; HASEGAWA T; NABESHIMA T
      ORAL-ADMINISTRATION OF IDEBENONE INDUCES NERVE GROWTH-FACTOR IN THE BRAIN AND IMPROVES LEARNING AND MEMORY IN BASAL FOREBRAIN-LESIONED RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    54. MACKEY D
      MISCONCEPTIONS ABOUT LEBER HEREDITARY OPTIC NEUROPATHY

      Medical journal of Australia
    55. TSURUO Y; ISHIMURA K; TAMURA M; KAGAWA S; MORITA K
      BIOCHEMICAL AND HISTOCHEMICAL-STUDIES OF THE EFFECTS OF CEREBRAL METABOLISM-IMPROVING DRUGS ON NADPH DIAPHORASE ACTIVITY IN MOUSE-BRAIN

      Japanese Journal of Pharmacology
    56. KAINOH M; UENO S; ENDOH T; NAKADATE T
      INHIBITORY EFFECT OF BERAPROST SODIUM ON FORMATION OF LIPID PEROXIDESIN ISCHEMIA AND RECIRCULATION-INDUCED CEREBRAL INJURY

      Pharmacological research
    57. NITTA A; HASEGAWA T; NABESHIMA T
      ORAL-ADMINISTRATION OF IDEBENONE, A STIMULATOR OF NGF SYNTHESIS, RECOVERS REDUCED NGF CONTENT IN AGED RAT-BRAIN

      Neuroscience letters
    58. NAITO M; HAYASHI T; YAMADA K; ASAI K; YOSHIMINE N; IGUCHI A
      PROTECTIVE EFFECTS OF IDEBENONE ON VASCULAR ENDOTHELIAL-CELLS AGAINSTTOXICITY INDUCED BY OXIDATIVELY MODIFIED LOW-DENSITY-LIPOPROTEIN

      Artery
    59. PELLEYMOUNTER MA; CULLEN MJ
      EFFECTS OF IDEBENONE ON INFORMATION-PROCESSING IN AGED LONG-EVANS RATS

      Pharmacology, biochemistry and behavior
    60. LATINI S; PEDATA F; PEPEU G
      EFFECT OF IDEBENONE ON ADENOSINE OUTFLOW AND ADENINE-NUCLEOTIDE LEVELIN HIPPOCAMPAL SLICES UNDER ISCHEMIA-LIKE CONDITIONS

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 02:06:47